1. Home
  2. CEPU vs STOK Comparison

CEPU vs STOK Comparison

Compare CEPU & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Puerto S.A. (each represents ten)

CEPU

Central Puerto S.A. (each represents ten)

HOLD

Current Price

$14.33

Market Cap

2.1B

Sector

Utilities

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.01

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEPU
STOK
Founded
1989
2014
Country
Argentina
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
CEPU
STOK
Price
$14.33
$29.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$17.50
$39.20
AVG Volume (30 Days)
250.3K
1.0M
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
$10.11
N/A
Revenue Next Year
N/A
$77.49
P/E Ratio
$12.24
N/A
Revenue Growth
N/A
404.50
52 Week Low
$7.43
$12.25
52 Week High
$18.50
$40.22

Technical Indicators

Market Signals
Indicator
CEPU
STOK
Relative Strength Index (RSI) 43.38 38.38
Support Level $13.87 $28.22
Resistance Level $16.45 $33.51
Average True Range (ATR) 0.57 1.56
MACD -0.04 -0.38
Stochastic Oscillator 20.42 12.29

Price Performance

Historical Comparison
CEPU
STOK

About CEPU Central Puerto S.A. (each represents ten)

Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity. The company derives maximum revenue from Electric Power Generation from conventional sources segment.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: